Dr. Jeffrey J. Kirshner
Claim this profileHematology Oncology Associates of Central New York-East Syracuse
Studies Cancer
Studies Lung Cancer
26 reported clinical trials
50 drugs studied
About Jeffrey J. Kirshner
Education:
- Obtained MD from the State University of New York at Buffalo, School of Medicine and Biomedical Sciences (1986).
- Completed Residency in Internal Medicine at the University of Rochester Medical Center (1989).
- Finished Fellowship in Hematology/Oncology at the University of Rochester Medical Center (1991).
Experience:
- Affiliated with Hematology Oncology Associates of Central New York-East Syracuse as a hematologist and oncologist.
Area of expertise
1Cancer
Stage IV
Stage III
HER2 positive
2Lung Cancer
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Jeffrey J. Kirshner is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Jeffrey J. Kirshner
Clinical Trial Related4 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Jeffrey J. Kirshner has experience with
- Carboplatin
- Atezolizumab
- Paclitaxel
- Pembrolizumab
- Leucovorin Calcium
- Fluorouracil
Breakdown of trials Jeffrey J. Kirshner has run
Cancer
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey J. Kirshner specialize in?
Jeffrey J. Kirshner focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jeffrey J. Kirshner currently recruiting for clinical trials?
Yes, Jeffrey J. Kirshner is currently recruiting for 9 clinical trials in East Syracuse New York. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey J. Kirshner has studied deeply?
Yes, Jeffrey J. Kirshner has studied treatments such as Carboplatin, Atezolizumab, Paclitaxel.
What is the best way to schedule an appointment with Jeffrey J. Kirshner?
Apply for one of the trials that Jeffrey J. Kirshner is conducting.
What is the office address of Jeffrey J. Kirshner?
The office of Jeffrey J. Kirshner is located at: Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York 13057 United States. This is the address for their practice at the Hematology Oncology Associates of Central New York-East Syracuse.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.